US FDA requests removal of suicide warnings from weight-loss drug labels

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...
MedPage Today on MSN

FDA Says to Drop Suicide Warning From GLP-1 Drug Labels

Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...
Axios on MSN

FDA calls on GLP-1 drugmakers to remove suicide warnings

The Food and Drug Administration on Tuesday told Eli Lilly and Novo Nordisk to remove warnings about the risk of suicidal ...
GlobalData on MSN

Drugmakers welcome FDA’s GLP-1RA suicide warning removal request

The request comes after a two-year review into reported links between GLP-1RAs and psychiatric adverse events.

FDA wants suicide warning removed from weight-loss drugs

The US Food and Drug Administration found no increased risk of suicidal behavior or ideation linked to popular weight-loss ...

FDA moves to remove suicide warnings from GLP-1 weight loss drugs

Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal ...

Popular weight-loss drugs shouldn't carry suicide warnings, FDA says

Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...

FDA removes the black box warning on hormone therapy for menopause

Hormone therapy helps women. Now the FDA is reversing its warning on estrogen treatment which could change treatemtn for ...
The Cardiology Advisor

FDA May Reduce How Often Supplement Warnings Appear on Labels

The FDA is weighing a change that could make warning labels on dietary supplements appear less often on packaging.
Fierce Pharma

FDA tells Sanofi, GSK, AZ and CSL to include warnings for febrile seizures on flu shot labels

The FDA has told the makers of six flu vaccines that they need to add a notification to the label of their shots, warning of ...
KSL

FDA requests removal of suicide warnings from weight-loss drug labels

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential ​risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli ...